ISSCA AI just got real. $RMTG actually detailed the whole platform.

{"summary": "Bullish thesis on RMTG based on its newly detailed ISSCA AI Clinical Intelligence Platform and multiple recurring revenue channels layered on an existing physician network.", "reason": "The author provides a fundamental rationale based on new revenue channels and historical financial performance to support a bullish outlook on RMTG.", "ideas": [{"symbol": "RMTG", "direction": "long", "thesis": "The author argues RMTG's newly detailed ISSCA AI Clinical Intelligence Platform is a real product, not vague AI talk, with a reasoning corpus of 1.6 million longitudinal health records and over 10,000 clinical studies. The commercial model adds four revenue channels (SaaS subscriptions via the existing physician network, patient longevity memberships, conference-based sales, and an ISSCA AI certification program) on top of existing training and product revenue, creating high-margin recurring revenue. The author cites Q2 revenue of $4.02M with $565K operating income and expects Q3 to be the tell, seeing close to $8M in revenue with potential upside if AI platform traction builds in the 30+ country, thousands-of-doctors network. Main risk implied is whether the SaaS and membership channels actually gain traction.", "thesis_short": "RMTG AI platform adds recurring revenue channels", "quote": "Q3 is going to be the tell. I think we see close to 8 million in revs and if the AI platform starts getting traction in the network that number could surprise people.", "confidence": 0.75, "sentiment": 0.8, "timeframe": "Q3 earnings"}], "model": "gemini-3.1-flash-lite", "failure_count": 0, "verified": true, "extraction_model": "deepseek-flash"}